| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02329314 | | ShuGuang Hospital | All | 60 | 2016-06-01 | 2014-12-01 |
| NCT00686881 | Hepatitis C, Chronic | Biological: Peginterferon alfa-2b (PegIFN-2b)|Drug: Comparator: Stronger neo minophagen C (SNMC) | Merck Sharp & Dohme Corp. | Phase 3 | 2006-12-01 | 2015-09-04 |
| NCT01643447 | Hepatocellular Carcinoma | Drug: Ulinastatin|Drug: Diammonium glycyrrhizinate | Eastern Hepatobiliary Surgery Hospital | | 2012-05-01 | 2016-03-30 |
| NCT01342185 | Chronic Hepatitis B | Device: medical ozone therapy with tianyi|Device: medical ozone therapy with humares|Drug: Diammonium glycyrrhizinate Capsules | Nanfang Hospital of Southern Medical University|Tianyi medical instruments limited company, Ningbo, China | Phase 3 | 2010-03-01 | 2012-10-17 |
| NCT02651350 | Drug-induced Liver Injury,Chronic | Drug: Methylprednisolone|Drug: Standard Treatment | Beijing 302 Hospital | Phase 1|Phase 2 | 2015-12-01 | 2016-11-15 |
| NCT02449109 | Liver Cancer | Procedure: interventional therapy | Fuda Cancer Hospital, Guangzhou | Phase 1|Phase 2 | 2015-05-01 | 2016-02-23 |
| NCT02449122 | Lung Cancer | Procedure: interventional therapy | Fuda Cancer Hospital, Guangzhou | Phase 1|Phase 2 | 2015-05-01 | 2016-02-23 |
| NCT02449135 | Pancreatic Cancer | Procedure: interventional therapy | Fuda Cancer Hospital, Guangzhou | Phase 1|Phase 2 | 2015-05-01 | 2016-02-23 |
| NCT02331745 | Liver Failure|Hepatitis B|Alcoholic Liver Disease | Drug: Granulocyte colony-stimulating factor|Drug: standard treatment | Beijing 302 Hospital | Phase 4 | 2013-10-01 | 2016-08-04 |
| NCT02473458 | Acute Stroke | Drug: Licorice whole extract|Drug: Placebo | Shiraz University of Medical Sciences | Phase 1|Phase 2 | 2012-06-01 | 2015-06-11 |
| NCT02251678 | Plaque Psoriasis | Dietary Supplement: Elimune Capsules | Elorac, Inc. | Phase 1 | 2014-09-01 | 2015-12-07 |
| NCT01271296 | Addison Disease | Dietary Supplement: Liquorice|Dietary Supplement: Grapefruit Juice | Haukeland University Hospital | | 2008-04-01 | 2011-01-13 |
| NCT00956891 | Liver Failure|Mesenchymal Stem Cells | | Sun Yat-sen University | Phase 1|Phase 2 | 2005-05-01 | 2010-12-06 |
| NCT01742702 | Primary Hypertension|Secondary Hypertension|Aortic Stenosis|Renal Insufficiency | Drug: Nitroglycerin 0.25 mg (single dose)|Drug: Salbutamol 400 g (single dose)|Drug: L-arginine (10 min infusion)|Dietary Supplement: Liquorice (2 weeks, glycyrrhizin 290-370 mg daily)|Dietary Supplement: Small milk casein-derived polypeptides (yoghurt, 12 weeks daily)|Drug: Bisoprolol (5mg daily for 3 weeks) | University of Tampere|Finnish Foundation for Cardiovascular Research|Paavo Nurmi Foundation|Sigrid Juselius Foundation|Finnish Cultural Foundation|Tampere Tuberculosis Foundation|The Competitive Research Funding of Pirkanmaa Hospital District|Aarne Koskelo Foundation|Finnish Medical Foundation|Orion Farmos Research Foundation|Finnish Kidney Foundation | Early Phase 1 | 2006-06-01 | 2012-12-03 |
| NCT00945568 | Hepatocellular Carcinoma|Chronic Liver Disease | Drug: Aminoleban EN | Kochi University | | 2007-05-01 | 2009-07-23 |
| NCT02812121 | Liver Failure | Drug: umbilical cord blood mesenchymal stem cells | Sun Yat-sen University | Phase 2 | 2016-06-01 | 2016-06-21 |
